amiodarone has been researched along with avapro in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Sen, S; Sinha, N | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bernal, E; Bueno, MG; Cabeza, P; Cano, JM; Cano, L; Madrid, AH; Marín, I; Moro, C; Peña, G; Rebollo, JM; Rodriguez, A | 1 |
| De Simone, A; Stabile, G; Turco, P | 1 |
| Bernal, E; Escobar, C; Limón, L; Madrid, AH; Marín, I; Moro, C; Nannini, S; Peng, J; Rebollo, JM | 1 |
| Cervantes, CE; Estévez, JE; Limón, L; Madrid, AH; Marín, IM; Morell, EB; Moreno, G; Moro, C; Nannini, S; Parajón, JR; Peng, J | 1 |
| Shen, SH; Xie, PY | 1 |
| Cao, DJ; Mu, CY; Tang, RB; Tong, F | 1 |
| Chen, LJ; Deng, XJ; Ding, P; Li, L; Yuan, YQ; Zhang, H | 1 |
| Kumagai, K | 1 |
| Cai, J; Feng, J; Ji, Q; Mei, Y; Sun, Y; Wang, X; Wusha, D; Xie, S | 1 |
3 review(s) available for amiodarone and avapro
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
Topics: Amiodarone; Angiotensin II Type 1 Receptor Blockers; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Drug Therapy, Combination; Humans; Irbesartan; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome | 2003 |
[Upstream approach for atrial fibrillation].
Topics: Amiodarone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Humans; Irbesartan; Tetrazoles | 2010 |
6 trial(s) available for amiodarone and avapro
| Article | Year |
|---|---|
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.
Topics: Adult; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Chronic Disease; Electric Countershock; Female; Follow-Up Studies; Humans; Irbesartan; Kinetics; Male; Middle Aged; Periodicity; Receptor, Angiotensin, Type 1; Recurrence; Tetrazoles | 2002 |
Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers.
Topics: Aged; Amiodarone; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Countershock; Female; Humans; Irbesartan; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Survival Analysis; Tetrazoles; Treatment Outcome | 2004 |
[Effect of combination of Chinese and Western medicines on sinus rhythm maintenance in patients with auricular fibrillation after conversion].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Irbesartan; Male; Middle Aged; Phytotherapy; Tetrazoles | 2006 |
[Clinical efficacy of irbesartan and amiodarone in elderly patients with paroxysmal atrial fibrillation].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Drug Therapy, Combination; Female; Humans; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2008 |
[Comparison of amiodarone plus irbesartan regimen versus amiodarone alone on maintaining sinus rhythm in rheumatic heart disease patients with persistent atrial fibrillation post valve replacement and cardioversion].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Female; Humans; Irbesartan; Male; Middle Aged; Rheumatic Heart Disease; Tetrazoles; Treatment Outcome | 2009 |
Combination of irbesartan and amiodarone to maintain sinus rhythm in patients with persistent atrial fibrillation after rheumatic valve replacement.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Biphenyl Compounds; Drug Therapy, Combination; Female; Heart Atria; Heart Valve Prosthesis Implantation; Humans; Irbesartan; Male; Middle Aged; Recurrence; Rheumatic Diseases; Tetrazoles; Treatment Outcome | 2010 |
9 other study(ies) available for amiodarone and avapro
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Sartan improves anti-arrhythmia therapy after cardioversion. Fewer recurrent fibrillation incidents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Humans; Irbesartan; Randomized Controlled Trials as Topic; Recurrence; Tetrazoles | 2002 |
Pretreatment of patients with atrial fibrillation who undergo electrical cardioversion.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Calcium Channel Blockers; Combined Modality Therapy; Drug Therapy, Combination; Electric Countershock; Humans; Irbesartan; Secondary Prevention; Tetrazoles | 2003 |